Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Duloxetine Compared With Placebo in Patients With Generalized Anxiety Disorder

This study has been completed.
Boehringer Ingelheim
Information provided by:
Eli Lilly and Company Identifier:
First received: July 20, 2005
Last updated: November 5, 2007
Last verified: November 2007
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: September 2005
  Estimated Primary Completion Date: No date given
Publications automatically indexed to this study by Identifier (NCT Number):